News

Anal cancer is relatively uncommon, accounting for approximately 2.5% of all gastrointestinal cancers. Nonetheless, its ...
Study authors examined the diagnostic utility of radiologic imaging for patients with high-risk cutaneous squamous cell carcinoma.
Several companies are advancing treatments for anal cancer, including Merck (KEYTRUDA), BioMimetix (BMX-001), Novartis (KFA115), and Bicara Therapeutics (BCA101), among others. As immunotherapy ...
The global population is aging rapidly, with the number of people aged 65 and older expected to double by 2050. This demographic shift is driving a s ...
Global Dermatology Devices Market is expected to grow at a rate of 12% by 2026. Growing awareness on dermatology devices for aesthetic treatments, growing cases of skin diseases & skin cancer, ...
That radiant glow you’re chasing by soaking up the sun could be doing more harm than good by raising your risk for skin ...
KØBENHAVN, DK / ACCESS Newswire / June 10, 2025 / FluoGuide A/S (STO:FLUO) - Copenhagen, Denmark - FluoGuide A/S ("FluoGuide" or the "Company"), a clinical-stage biotech company focused on precision ...
Who doesn't love spending more time in the summer sun? However, it's important to protect your skin and check for signs of skin cancer.
DelveInsight’s Natural Killer (NK)-Cell Lymphoma Pipeline report depicts a robust space with 100+ active players working to develop 140+ pipeline therapies for Natural Killer (NK)-Cell Lymphoma ...
When you think of laser treatments, you probably picture brighter skin and fewer wrinkles. But what if that same zap of light ...
AIM To evaluate the clinical features, treatment results, and recurrence rates in patients with either intraepithelial or invasive squamous cell carcinoma of the conjunctiva. METHODS Retrospective ...